More China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class ASZSE: 000999 China Resources Sanjiu Medical & Pharmaceutical Q1 Net Profit Down 15.3% Y/Y Apr 24, 2026 at 10:28 AM UTC · Issued by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A As issuedPlain English China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999:Q1 NET PROFIT DOWN 15.3% Y/Y Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class AChina Resources Sanjiu Medical & Pharmaceutical Co: 2025 revenue up 14.43%, net profit up 1.58%, with robust R&D and major acquisitionMar 21China Resources Sanjiu Medical & Pharma's 2025 Net Profit Up 1.6% Y/YMar 20China Resources Sanjiu Medical & Pharmaceutical Prelim 2025 Net Profit Up 1.6%Feb 6China Resources Sanjiu Medical & Pharmaceutical Co: Revenue surged but profit declined as acquisition and investment costs rose sharplyOct 25, 2025All China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news releases↗